Insife

Copenhagen, Denmark Founded: 2017 • Age: 9 yrs Acquired By Qinecsa
Pharmacovigilance consulting services are provided to pharma, biotech, and agencies.

About Insife

Insife is a Healthcare company based in Copenhagen (Denmark) founded in 2017 by Martin Holm-Petersen, and was acquired by Qinecsa in March 2024. Pharmacovigilance consulting services are provided to pharma, biotech, and agencies. The company has 27 employees. Its chief executive, as recorded, is Martin Holm-Petersen. Its Indian entity Insife India Private Limited reported revenue of β‚Ή16.93 Cr. Insife offers products and services including HaloPV and GRIP. Its focus areas include HealthTech, Life Sciences Tech, GRC Solutions and Pharmacovigilance.

Company details

Insife offers pharmacovigilance consulting services for pharma, biotech, and national agencies. They provide services for regulatory intelligence, PV agreements organizational entity management, risk management (documentscommitments), literature monitoring, program oversight (MSP MRP), scanning of websites and social media. Softwares for pharmacovigilance includes Argus safety database system, OBIEE analytical, TransformPV, etc. Demystifier is the software for clinical data standardization, HiLIT is a cloud-based integrated analytics platform, ClinINT is developed that collects, integrates and manage structured and unstructured clinical data.

  • Headquarters Copenhagen, Denmark
  • Employees 27
  • Founders Martin Holm-Petersen
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website insife.com
  • Social LinkedIn Facebook
  • Acquired by Qinecsa (Mar 2024)
  • Legal Name Insife India Private Limited
  • Date of Incorporation 29 Nov, 2018
  • Jurisdiction Bengaluru, Karnataka, India
Key Metrics
  • Indian entity revenue
    ₹16.93 Cr

    FY 2025 · +54% YoY

  • Indian entity net profit
    ₹1.58 Cr

    FY 2025 · 9% margin

  • Indian entity EBITDA
    ₹2.56 Cr

    FY 2025 · 15% margin

  • Investors
  • Employee Count
    27
  • Acquired by
    Qinecsa

    (Mar 2024)

Products & Services of Insife

Insife offers a comprehensive portfolio of products and services, including HaloPV and GRIP.

HaloPV
Pharmacovigilance Software

Automates case intake and data management for drug safety processes.

GRIP
Regulatory Intelligence Platform

Delivers intelligence on regulations across 165 countries.

Investors in Insife

Insife has secured backing from 1 investor. Prominent investors backing the company include Qinecsa.

All
InvestorDescriptionFounded YearDomainLocation
Provides pharmacovigilance technology and services for drug safety management globally.
2022qinecsa.comLondon, United Kingdom
Premium access

Investor details for Insife

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Insife India Private Limited (Insife)

Insife India Private Limited is the primary company behind Insife. The board of Insife India Private Limited currently have 2 directors; the longest-serving is Leena Kathpalia, appointed in 2023. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Leena Kathpalia
DIN 10140696
Director02 May 20233 yrs 6 moInsife India Private Limited
Adam Sherlock
DIN 09428222
Additional Director19 Sep 20251 yr 1 moInsife India Private Limited

People of Insife

13 people are tracked at Insife (5 in leadership, 8 in team); the tracked headcount is 27.

NameRoleGroup
Martin Holm-Petersen
Founder & CEOLeadership
Praveen Gupta
Global Head (vp) Digital InnovationLeadership
Simon Russell
Head Of Product ManagementLeadership
Lourdes Ruiz
Head Of Data Science And AILeadership
Managing Director Of Insife India And VP Of Global Service CenterLeadership
Alok Kushwah
Product ManagerTeam
Abnish Kumar
Technical ArchitectTeam
Sanchita Khanduri
Product ManagerTeam
Katarina Mage
Business AnalystTeam
Bharat Chander
HRTeam
Mara Majić
Business AnalystTeam
Madan Lal
Technical ConsultantTeam
Amit Kumar
Technical ArchitectTeam
Premium access

Complete people profiles for Insife

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Insife

Figures of Insife India Private Limited, the primary company behind Insife, for FY 2025. Revenue was ₹16.93 Cr (+54% year on year). Net profit was ₹1.58 Cr (9% margin). EBITDA was ₹2.56 Cr (15% margin). Revenue has grown at a compounded annual rate of +68% over three years and +77% over five years.

  • ₹16.93 CrRevenue · FY 2025 · +54% YoY
  • ₹1.58 CrNet profit · 9% margin
  • ₹2.56 CrEBITDA · 15% margin
  • ₹1 LakhPaid-up capital
  • 27Employees (provident fund records)
  • +68%Revenue CAGR, 3 years
  • +77%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Insife India Private Limited are on its company page.

Premium access

Detailed financial statements for Insife

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Insife

2 dated milestones of Insife across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Insife is founded.
  2. Exit Acquired by Qinecsa.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Insife

Qinecsa Solutions Acquires Insife
Contractpharma β€’ 2 years ago
Premium access

Complete news archive for Insife

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Insife

Insife was founded in 2017.

Insife is headquartered in Copenhagen, Denmark.

Martin Holm-Petersen is the CEO of Insife, as recorded in our data. They have also founded this company.

Insife has 27 employees.

The primary company behind Insife, Insife India Private Limited, reported revenue of β‚Ή16.93 Cr for FY 2025, up 54% year on year.

Insife offers pharmacovigilance consulting services for pharma, biotech, and national agencies. They provide services for regulatory intelligence, PV agreements organizational entity management, risk management (documentscommitments), literature monitoring, program oversight (MSP MRP), scanning of websites and social media. Softwares for pharmacovigilance includes Argus safety database system, OBIEE analytical, TransformPV, etc. Demystifier is the software for clinical data standardization, HiLIT is a cloud-based integrated analytics platform, ClinINT is developed that collects, integrates and manage structured and unstructured clinical data.

Insife offers HaloPV and GRIP.

Insife has 1 investor. Key investors include Qinecsa.

Insife operates through Insife India Private Limited.

Yes. Insife was acquired by Qinecsa in March 2024.

The legal entities of Insife currently have 2 directors, including Leena Kathpalia, Adam Sherlock.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available